Cephalon

Teva’s Cephalon acquisition could be delayed

June 15, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Cephalon, Teva

The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month. …

Merck & Co

Merck to develop biosimilar of Pfizer’s Enbrel

June 15, 2011
Research and Development, Sales and Marketing Enbrel, Merck & Co, biosimilar

Merck & Co is to develop its own version of Pfizer’s ageing arthritis drug Enbrel with a South Korean manufacturer. …

Future Forum recommends major amendments to Health Bill

June 14, 2011
Health and Social Care Bill, NHS reforms

The role of GPs and competition in the government’s Health Bill should be greatly diluted and its reform programme substantially …

Xceleron appoints Dr Stuart Best

June 14, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Dr Stuart Best has joined Xceleron as senior director operations, moving to the company from Merck in Scotland where he …

FDA plea for notice on drug shortages

June 14, 2011
Manufacturing and Production FDA, pharma manufacturing

The FDA has asked US drugmakers to give advance warning of production problems which could lead to shortages in available …

Pharma manufacturing news in brief

June 14, 2011
Manufacturing and Production pharma manufacturing

Baxter loses first heparin lawsuit, Pfizer plans a branded generics push in China, plus there’s updates from GSK, Hovione and …

Pfizer's Sandwich, Kent research site

Pfizer’s Sandwich site on market as ‘discovery park’

June 14, 2011
Research and Development Pfizer, Sandwich, UK pharma

Pfizer has expanded its options for its main European research site, earmarked for closure in Feburary, and is now marketing …

Merck redesigns drug labels for clarity

June 14, 2011
Manufacturing and Production FDA, Labelling, Merck & Co

The FDA has approved a major overhaul of labelling for a range of Merck & Co products, paving the way …

Blog footer

Digital Pharma: The rise of the European e-patient

June 14, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, online health information

The number of people in Europe who go online to look for health information has more than doubled over the …

Innovation – is it science or art?

June 14, 2011
Manufacturing and Production, Research and Development creativity, drug development, innovation

In recent times new drug development has shown a substantial decline in the number of approved drugs for human use. …

Gilead manufacturing under investigation by US authorities

June 14, 2011
Manufacturing and Production Department of Justice, Gilead, manufacturing compliance, pharma manufacturing

Gilead Sciences is being investigated by the US authorities over the manufacturing and distribution of some of its products, and …

Brand(x) rebrands to ICC Lowe

June 13, 2011
Medical Communications Brand(x), ICC Lowe, medical communications

Brand(x) is changing its name to ICC Lowe and will act as the London office for its expanding US parent …

Merck KGaA readies phase III brain cancer trial

June 13, 2011
Research and Development Merck KGaA, brain cancer, cilengitide, glioblastoma

Merck KGaA has completed patient enrollment for a phase III global trial of its first-in-class integrin inhibitor in a rare …

Daniel Elger joins e-Therapeutics

June 13, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

UK and India-based e-Therapeutics has appointed Dr Daniel Elger as chief financial officer. He joins the drug discovery company from …

networks_in_health_beverly_stainsby

Networks in Health appoints Beverly Stainsby

June 13, 2011
Sales and Marketing appointment, sales and marketing

Beverly Stainsby has joined Networks in Health, an alliance of online doctors’ communities, as international account director. She joins from …

European pharma’s compliance challenge

June 13, 2011
Sales and Marketing global regulatory landscape, regulatory affairs, regulatory compliance

Life Sciences companies across Europe are facing a series of emerging global legislation and increased regulatory enforcement, designed to prevent …

GlaxoSmithKline

GSK’s epilepsy treatment Potiga wins US approval

June 13, 2011
Sales and Marketing GSK, Potiga, Trobalt, Valeant, epilepsy

The FDA has approved GlaxoSmithKline and Valeant’s epilepsy treatment Potiga, but the drug will require further review before it can …

Takeda Actos (pioglitazone)

France pulls Takeda diabetes drugs after cancer fears

June 13, 2011
Sales and Marketing Actos, Competact, EMA, Takeda

The French medicines agency has moved to prevent two Takeda diabetes drugs from being prescribed after fears they could increase …

New Priorclave Autoclave Bound to be First

June 10, 2011
Manufacturing and Production

Although it provides for increased loading, the combination of forced air cooling reduces cycle times and automatic timed free-steaming improves …

Digital Pharma: European doctors turn to the social web

June 10, 2011
Medical Communications Digital Pharma blog, digital doctors, social media

European GPs are making increasing use of the social web and new research has shown Wikipedia to be the most …

The Gateway to Local Adoption Series

Latest content